Efficacy Study of Vigabatrin to Treat Meth Dependence(CA, FL, KY, LA, MO, NE, OK, TX)

The objective of this study is to demonstrate that a larger proportion of vigabatrin-treated subjects than placebo-treated subjects will be methamphetamine-free in the last 2 weeks of the study's Treatment Phase (Weeks 11 and 12).

Vigabatrin is a drug that inhibits the catabolism of GABA, acting as a sedative. It has previously been found effective for methamphetamine dependence.

Estimated Enrollment: 180
Study Start Date: July 2008
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)

Contacts
Contact: Douglas Winship (305) 529-2522 ext 12 [email protected]

Locations
United States, California
North County Clinical Research (NCCR) Recruiting
Oceanside, California, United States
Contact: Angela Hunt 760-639-4378
Addiction Pharmacology Research Laboratory, St. Luke's Hospital Recruiting
San Francisco, California, United States
Contact: Kathleen Garrison 415-641-3370
South Bay Treatment Center Recruiting
San Diego, California, United States
Contact: Andrea Jaks 800-495-0001
Contact (619) 395-0711

United States, Florida
Segal Institute for Clinical Research Recruiting
N. Miami, Florida, United States
Contact: Gustavo Rodriguez 877-734-2588

United States, Kentucky
Center on Drug and Alcohol Research, University of Kentucky Recruiting
Lexington, Kentucky, United States
Contact: Lisa Middleton, PhD 859-323-3106
Contact 866-933-4859

United States, Louisiana
Lake Charles Clinical Trials Recruiting
Lake Charles, Louisiana, United States
Contact: Danette Beard 337-494-3266
Contact: Colleen Smith 337-494-3266

United States, Missouri
START Research and Treatment Recruiting
Kansas City, Missouri, United States
Contact: Carolyn Rowe 816-444-5455
Contact: Valerie Brown-Davis (816) 444-5455

United States, Nebraska
Creighton University Medical Center Recruiting
Omaha, Nebraska, United States
Contact: Wendy Taylor 402-345-8828 ext 20
Contact: Jodette Rose 402-345-8828 ext 20

United States, New Mexico
Behavioral Health Research Center of the Southwest Recruiting
Albuquerque, New Mexico, United States
Contact: Valerie Wada 505-244-3099
Contact: Patricia Hokanson (505) 244-3099

United States, Oklahoma
Pahl Pharmaceutical Research Recruiting
Oklahoma City, Oklahoma, United States
Contact: Gail Carpenter 405-525-2222
Contact: Ursula Pahl 405-525-2222

United States, Texas
Pillar Research Recruiting
Dallas, Texas, United States
Contact: Brian Craig 214-341-1953
Contact: Courtney Stewart (214) 341-1953

http://clinicaltrials.gov/ct2/show/NCT00730522

I wonder if that means gabapentin could be used to ease a bad meth trip

Study appears to have been terminated due to budgetary concerns.

http://clinicaltrials.gov/ct2/show/NCT00730522